Follow
Therapy
Therapy: is the attempted remediation of a health problem, usually following a diagnosis. In the medical field, it is usually synonymous with treatment.
NOV 04, 2020 | 11:00 AM
DATE: November 4th, 2020 TIME: 11:00am PST As cell therapies become more complex, the need for robust analytical tools to characterize such products as they enter the clinic has increased in...
NOV 04, 2020 | 6:00 AM
Date: November 4, 2020 Time: 6:00am (PDT), 9:00am (EDT) The Global Scar Society was formed to gain consensus for and promote best practice in the prevention and treatment of abnormal & e...
OCT 28, 2020 | 7:00 AM
Date: October 28, 2020 Time: 7:00am (PDT), 10:00am (EDT) Although chemotherapy remains the mainstay of systemic therapy, a large number of cancer patients fail to respond to it. About half o...
OCT 21, 2020 | 10:35 PM
The treatment of cancer has remarkably improved because of increased knowledge of the molecular abnormalities that drive human cancer growth. This has led to the development of ever more eff...
OCT 21, 2020 | 10:35 PM
The treatment of cancer has remarkably improved because of increased knowledge of the molecular abnormalities that drive human cancer growth. This has led to the development of ever more eff...
OCT 21, 2020 | 9:25 PM
High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
OCT 21, 2020 | 9:25 PM
High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
OCT 21, 2020 | 9:05 PM
There is an expanding list of therapeutically relevant biomarkers for non-small cell lung cancer (NSCLC), and molecular profiling at diagnosis is paramount. Tissue attrition in scaling tradi...
OCT 21, 2020 | 9:05 PM
There is an expanding list of therapeutically relevant biomarkers for non-small cell lung cancer (NSCLC), and molecular profiling at diagnosis is paramount. Tissue attrition in scaling tradi...
OCT 21, 2020 | 9:00 AM
DATE: October 21, 2020 TIME: 08:00am PT Learning Objectives: Describe Inflammatory Bowel Disease (IBD) pathophysiology and epidemiology Understand treat to target goals Review role of fecal...
OCT 20, 2020 | 9:00 AM
DATE: October 20th, 2020 TIME: 08:00am PT, 11:00am ET Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) with diverse immune functions that have a major in...
OCT 13, 2020 | 8:00 AM
C.E. CREDITS
Learn how D-dimer testing aids VTE diagnosis, risk stratification, and PE prevention, with insights on medically ill and COVID-19 patients....
